Search for: "U.S. v. Daniel*" Results 3101 - 3111 of 3,111
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
21 Oct 2019, 6:00 am by Brian Gallini
In its well-known decision of Illinois v. [read post]
5 Jan 2017, 2:22 pm by Robert B. Milligan
While the circuit court split continues to widen regarding the interpretation of unauthorized access under the Computer Fraud and Abuse Act, the recent decision in U.S. v. [read post]
5 Jan 2017, 2:22 pm by Robert B. Milligan
While the circuit court split continues to widen regarding the interpretation of unauthorized access under the Computer Fraud and Abuse Act, the recent decision in U.S. v. [read post]
27 Jun 2023, 9:01 pm by renholding
Congress has been very clear in the federal securities laws when it intends to preempt state law, such as in the National Securities Markets Improvement Act[44] or the Jumpstart Our Business Startups Act.[45] Indeed, such a broad claim of Commission authority might raise issues under the major questions doctrine discussed in West Virginia v. [read post]
12 Mar 2012, 8:13 am by Ronald Collins
  So far as books by Justices are concerned, this new offering is more refined, extensive, and current than what had appeared previously in Fenton Martin and Robert Goehlert’s The U.S. [read post]
16 Sep 2009, 1:47 pm
(Manchester, MA; Daniel Croce, President) Aela Corporation (Burlington, MA; Aela Oh, President) Aepx Animation, Inc. [read post]
13 Apr 2024, 3:33 pm by admin
Prelude to Litigation Phenylpropanolamine (PPA) was a widely used direct α-adrenergic agonist used as a medication to control cold symptoms and to suppress appetite for weight loss.[1] In 1972, an over-the-counter (OTC) Advisory Review Panel considered the safety and efficacy of PPA-containing nasal decongestant medications, leading, in 1976, to a recommendation that the agency label these medications as “generally recognized as safe and effective. [read post]